Supporter of | Dick Gephardt |
Supported by | HARPA Health Advanced Projects Research Agency |
Notes | "90% of what Pharma takes out into that long pathway to bedside fails. And so all the capital that they put into clinical trials, into applied research, is down the drain. So this whole pathway from bench to bedside is not being treated carefully." Dick Gephardt, Member of the House of Representatives 1976-2004 |